Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| EQUIFAX INCEFX · Entity 3235 | EVP, Chief Technology Officer | February 25, 2026 | February 27, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
EQUIFAX INC
Report date February 25, 2026 · Filed February 27, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 54,090 |
Reported balance
After 2026-02-25 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2026-02-25 · Grant · Acquired 14,221 · Balance 54,090 F1: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 25, 2029. F2: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 400 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 25, 2029.
F2: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 400 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 25, 2026 Filed Feb 27, 2026 21:14 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 14,221 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-002758 · doc4.xml · nonDerivative · entry 1 Farshchi Jamil · CIK 0001732980 · EVP, Chief Technology Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,090 F1 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 25, 2029. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 400 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan. Read SEC document |
| February 11, 2026 Filed Feb 12, 2026 21:08 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 1,167 | $199.87 | $233,248.29 |
DisclosureSEC source: 0001225208-26-001769 · doc4.xml · nonDerivative · entry 5 Farshchi Jamil · CIK 0001732980 · EVP, Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 39,869 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 4/25/2025. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 400 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 21:08 UTC | EQUIFAX INC EFX · Entity 3235 | Exercise / conversionStock Option/Right to Buy · Derivative | 6,213 | $0.00 Strike: $191.44 | $0.00 |
DisclosureSEC source: 0001225208-26-001769 · doc4.xml · derivative · entry 6 Farshchi Jamil · CIK 0001732980 · EVP, Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,213 shares Expires 2026-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested in three equal annual increments beginning 2/21/2021. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 21:08 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 6,213 | $195.81 | $1,216,567.53 |
DisclosureSEC source: 0001225208-26-001769 · doc4.xml · nonDerivative · entry 4 Farshchi Jamil · CIK 0001732980 · EVP, Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 41,036 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 4/25/2025. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 400 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 21:08 UTC | EQUIFAX INC EFX · Entity 3235 | Tax withholdingCommon Stock | 3,042 | $202.71 | $616,643.82 |
DisclosureSEC source: 0001225208-26-001769 · doc4.xml · nonDerivative · entry 3 Farshchi Jamil · CIK 0001732980 · EVP, Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 47,249 F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 400 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 21:08 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 4,667 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-26-001769 · doc4.xml · nonDerivative · entry 2 Farshchi Jamil · CIK 0001732980 · EVP, Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 50,291 F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 400 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan. Read SEC document |
| February 10, 2026 Filed Feb 12, 2026 21:08 UTC | EQUIFAX INC EFX · Entity 3235 | Exercise / conversionCommon Stock | 6,213 | $191.44 | $1,189,416.72 |
DisclosureSEC source: 0001225208-26-001769 · doc4.xml · nonDerivative · entry 1 Farshchi Jamil · CIK 0001732980 · EVP, Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 45,624 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 4/25/2025. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 400 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan. Read SEC document |
| October 27, 2025 Filed Oct 28, 2025 20:11 UTC | EQUIFAX INC EFX · Entity 3235 | Exercise / conversionStock Option/Right to Buy · Derivative | 4,925 | $0.00 Strike: $175.48 | $0.00 |
DisclosureSEC source: 0001225208-25-008751 · doc4.xml · derivative · entry 3 Farshchi Jamil · CIK 0001732980 · EVP, Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,925 shares Expires 2026-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The option vested in three equal annual increments beginning 2/21/2021. Read SEC document |
| October 27, 2025 Filed Oct 28, 2025 20:11 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 4,925 | $238.94 | $1,176,779.50 |
DisclosureSEC source: 0001225208-25-008751 · doc4.xml · nonDerivative · entry 2 Farshchi Jamil · CIK 0001732980 · EVP, Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 39,364 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 4/25/2025. F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 372 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan. Read SEC document |
| October 27, 2025 Filed Oct 28, 2025 20:11 UTC | EQUIFAX INC EFX · Entity 3235 | Exercise / conversionCommon Stock | 4,925 | $175.48 | $864,239.00 |
DisclosureSEC source: 0001225208-25-008751 · doc4.xml · nonDerivative · entry 1 Farshchi Jamil · CIK 0001732980 · EVP, Chief Technology Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 44,289 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 372 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan. Read SEC document |
| February 12, 2025 Filed Feb 13, 2025 21:13 UTC | EQUIFAX INC EFX · Entity 3235 | Exercise / conversionStock Option/Right to Buy · Derivative | 13,367 | $0.00 Strike: $149.53 | $0.00 |
DisclosureSEC source: 0001225208-25-001647 · doc4.xml · derivative · entry 7 Farshchi Jamil · CIK 0001732980 · EVP, CISO & CTO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,367 shares Expires 2025-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 12, 2025 Filed Feb 13, 2025 21:13 UTC | EQUIFAX INC EFX · Entity 3235 | Exercise / conversionStock Option/Right to Buy · Derivative | 5,544 | $0.00 Strike: $138.45 | $0.00 |
DisclosureSEC source: 0001225208-25-001647 · doc4.xml · derivative · entry 6 Farshchi Jamil · CIK 0001732980 · EVP, CISO & CTO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,544 shares Expires 2025-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 12, 2025 Filed Feb 13, 2025 21:13 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 18,911 | $248.18 | $4,693,331.98 |
DisclosureSEC source: 0001225208-25-001647 · doc4.xml · nonDerivative · entry 5 Farshchi Jamil · CIK 0001732980 · EVP, CISO & CTO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 39,252 F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 8/27/2024. F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 306 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan. Read SEC document |
| February 12, 2025 Filed Feb 13, 2025 21:13 UTC | EQUIFAX INC EFX · Entity 3235 | Exercise / conversionCommon Stock | 5,544 | $138.45 | $767,566.80 |
DisclosureSEC source: 0001225208-25-001647 · doc4.xml · nonDerivative · entry 4 Farshchi Jamil · CIK 0001732980 · EVP, CISO & CTO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 58,163 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 8/27/2024. F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 306 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan. Read SEC document |
| February 12, 2025 Filed Feb 13, 2025 21:13 UTC | EQUIFAX INC EFX · Entity 3235 | Exercise / conversionCommon Stock | 13,367 | $149.53 | $1,998,767.51 |
DisclosureSEC source: 0001225208-25-001647 · doc4.xml · nonDerivative · entry 3 Farshchi Jamil · CIK 0001732980 · EVP, CISO & CTO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,619 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 8/27/2024. F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 306 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan. Read SEC document |
| February 11, 2025 Filed Feb 13, 2025 21:13 UTC | EQUIFAX INC EFX · Entity 3235 | Tax withholdingCommon Stock | 1,775 | $253.00 | $449,075.00 |
DisclosureSEC source: 0001225208-25-001647 · doc4.xml · nonDerivative · entry 2 Farshchi Jamil · CIK 0001732980 · EVP, CISO & CTO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 39,252 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 306 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan. Read SEC document |
| February 11, 2025 Filed Feb 13, 2025 21:13 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 2,373 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-001647 · doc4.xml · nonDerivative · entry 1 Farshchi Jamil · CIK 0001732980 · EVP, CISO & CTO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 41,027 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 306 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 21:15 UTC | EQUIFAX INC EFX · Entity 3235 | GrantStock Option/Right to Buy · Derivative | 11,910 | $0.00 Strike: $252.90 | $0.00 |
DisclosureSEC source: 0001225208-25-001580 · doc4.xml · derivative · entry 2 Farshchi Jamil · CIK 0001732980 · EVP, CISO & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,910 Underlying: Common Stock · 11,910 shares Expires 2035-02-10 F3 · derivative.exercise_date: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning February 10, 2026. Read SEC document |
| February 10, 2025 Filed Feb 12, 2025 21:15 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 3,707 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-001580 · doc4.xml · nonDerivative · entry 1 Farshchi Jamil · CIK 0001732980 · EVP, CISO & CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 38,654 F1 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 10, 2028. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date and 306 shares of common stock purchased pursuant to the Equifax Inc. 2020 Employee Stock Purchase Plan. Read SEC document |
| November 26, 2024 Filed Nov 27, 2024 21:14 UTC | EQUIFAX INC EFX · Entity 3235 | Exercise / conversionStock Option/Right to Buy · Derivative | 9,171 | $0.00 Strike: $127.37 | $0.00 |
DisclosureSEC source: 0001225208-24-010249 · doc4.xml · derivative · entry 5 Farshchi Jamil · CIK 0001732980 · EVP, CISO & Acting CTO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 9,171 shares Expires 2025-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 26, 2024 Filed Nov 27, 2024 21:14 UTC | EQUIFAX INC EFX · Entity 3235 | Exercise / conversionStock Option/Right to Buy · Derivative | 5,545 | $0.00 Strike: $138.45 | $0.00 |
DisclosureSEC source: 0001225208-24-010249 · doc4.xml · derivative · entry 4 Farshchi Jamil · CIK 0001732980 · EVP, CISO & Acting CTO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 5,544 Underlying: Common Stock · 5,545 shares Expires 2025-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 26, 2024 Filed Nov 27, 2024 21:14 UTC | EQUIFAX INC EFX · Entity 3235 | SaleCommon Stock | 14,716 | $260.39 | $3,831,899.24 |
DisclosureSEC source: 0001225208-24-010249 · doc4.xml · nonDerivative · entry 3 Farshchi Jamil · CIK 0001732980 · EVP, CISO & Acting CTO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 34,632 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 8/27/2024. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| November 26, 2024 Filed Nov 27, 2024 21:14 UTC | EQUIFAX INC EFX · Entity 3235 | Exercise / conversionCommon Stock | 5,545 | $138.45 | $767,705.25 |
DisclosureSEC source: 0001225208-24-010249 · doc4.xml · nonDerivative · entry 2 Farshchi Jamil · CIK 0001732980 · EVP, CISO & Acting CTO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 49,348 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 8/27/2024. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| November 26, 2024 Filed Nov 27, 2024 21:14 UTC | EQUIFAX INC EFX · Entity 3235 | Exercise / conversionCommon Stock | 9,171 | $127.37 | $1,168,110.27 |
DisclosureSEC source: 0001225208-24-010249 · doc4.xml · nonDerivative · entry 1 Farshchi Jamil · CIK 0001732980 · EVP, CISO & Acting CTO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 43,803 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 8/27/2024. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 20, 2024 Filed Feb 21, 2024 21:08 UTC | EQUIFAX INC EFX · Entity 3235 | GrantStock Option/Right to Buy · Derivative | 2,494 | $0.00 Strike: $257.85 | $0.00 |
DisclosureSEC source: 0001225208-24-002599 · doc4.xml · derivative · entry 2 Farshchi Jamil · CIK 0001732980 · EVP, CISO & Acting CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,494 Underlying: Common Stock · 2,494 shares Expires 2034-02-09 F3 · derivative.exercise_date: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning February 9, 2025. Read SEC document |
| February 20, 2024 Filed Feb 21, 2024 21:08 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 776 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002599 · doc4.xml · nonDerivative · entry 1 Farshchi Jamil · CIK 0001732980 · EVP, CISO & Acting CTO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,605 F1 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 9, 2027. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 21:49 UTC | EQUIFAX INC EFX · Entity 3235 | Tax withholdingCommon Stock | 2,133 | $255.78 | $545,578.74 |
DisclosureSEC source: 0001225208-24-002066 · doc4.xml · nonDerivative · entry 2 Farshchi Jamil · CIK 0001732980 · EVP, CISO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,829 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 12, 2024 Filed Feb 14, 2024 21:49 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 3,286 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-002066 · doc4.xml · nonDerivative · entry 1 Farshchi Jamil · CIK 0001732980 · EVP, CISO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,962 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 21:10 UTC | EQUIFAX INC EFX · Entity 3235 | GrantStock Option/Right to Buy · Derivative | 5,484 | $0.00 Strike: $249.18 | $0.00 |
DisclosureSEC source: 0001225208-24-001929 · doc4.xml · derivative · entry 2 Farshchi Jamil · CIK 0001732980 · EVP, CISO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,484 Underlying: Common Stock · 5,484 shares Expires 2034-02-09 F3 · derivative.exercise_date: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning February 9, 2025. Read SEC document |
| February 09, 2024 Filed Feb 13, 2024 21:10 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 1,706 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-001929 · doc4.xml · nonDerivative · entry 1 Farshchi Jamil · CIK 0001732980 · EVP, CISO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,676 F1 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 9, 2027. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 21:07 UTC | EQUIFAX INC EFX · Entity 3235 | Tax withholdingCommon Stock | 2,198 | $203.81 | $447,974.38 |
DisclosureSEC source: 0001225208-23-002657 · doc4.xml · nonDerivative · entry 2 Farshchi Jamil · CIK 0001732980 · EVP, CISO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,933 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 21, 2023 Filed Feb 23, 2023 21:07 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 3,426 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002657 · doc4.xml · nonDerivative · entry 1 Farshchi Jamil · CIK 0001732980 · EVP, CISO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,131 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:14 UTC | EQUIFAX INC EFX · Entity 3235 | GrantStock Option/Right to Buy · Derivative | 6,572 | $0.00 Strike: $206.16 | $0.00 |
DisclosureSEC source: 0001225208-23-001890 · doc4.xml · derivative · entry 2 Farshchi Jamil · CIK 0001732980 · EVP, CISO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,572 Underlying: Common Stock · 6,572 shares Expires 2033-02-10 F3 · derivative.exercise_date: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning February 10, 2024. Read SEC document |
| February 10, 2023 Filed Feb 14, 2023 21:14 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 2,062 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-001890 · doc4.xml · nonDerivative · entry 1 Farshchi Jamil · CIK 0001732980 · EVP, CISO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,705 F1 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on February 10, 2026. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 21:11 UTC | EQUIFAX INC EFX · Entity 3235 | Tax withholdingCommon Stock | 6,292 | $212.24 | $1,335,414.08 |
DisclosureSEC source: 0001225208-22-003261 · doc4.xml · nonDerivative · entry 2 Farshchi Jamil · CIK 0001732980 · CISO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 27,610 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 22, 2022 Filed Feb 24, 2022 21:11 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 12,207 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-003261 · doc4.xml · nonDerivative · entry 1 Farshchi Jamil · CIK 0001732980 · CISO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,902 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 11, 2022 Filed Feb 15, 2022 22:34 UTC | EQUIFAX INC EFX · Entity 3235 | GrantStock Option/Right to Buy · Derivative | 6,217 | $0.00 Strike: $225.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002191 · doc4.xml · derivative · entry 2 Farshchi Jamil · CIK 0001732980 · CISO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,217 Underlying: Common Stock · 6,217 shares Expires 2032-02-11 F3 · derivative.exercise_date: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning 2/11/2023. Read SEC document |
| February 11, 2022 Filed Feb 15, 2022 22:34 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 1,556 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-002191 · doc4.xml · nonDerivative · entry 1 Farshchi Jamil · CIK 0001732980 · CISO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,695 F1 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on 2/11/2025. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 21:20 UTC | EQUIFAX INC EFX · Entity 3235 | Tax withholdingCommon Stock | 3,090 | $169.75 | $524,527.50 |
DisclosureSEC source: 0001225208-21-004917 · doc4.xml · nonDerivative · entry 2 Farshchi Jamil · CIK 0001732980 · CISO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,103 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| March 05, 2021 Filed Mar 9, 2021 21:20 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 5,247 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-004917 · doc4.xml · nonDerivative · entry 1 Farshchi Jamil · CIK 0001732980 · CISO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,193 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 22:22 UTC | EQUIFAX INC EFX · Entity 3235 | GrantStock Option/Right to Buy · Derivative | 5,643 | $0.00 Strike: $177.19 | $0.00 |
DisclosureSEC source: 0001225208-21-002792 · doc4.xml · derivative · entry 2 Farshchi Jamil · CIK 0001732980 · CISO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,643 Underlying: Common Stock · 5,643 shares Expires 2031-02-12 F3 · derivative.exercise_date: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning 2/12/2022. Read SEC document |
| February 12, 2021 Filed Feb 17, 2021 22:22 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 1,411 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-002792 · doc4.xml · nonDerivative · entry 1 Farshchi Jamil · CIK 0001732980 · CISO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,946 F1 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on 2/12/2024. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| March 05, 2020 Filed Mar 9, 2020 20:23 UTC | EQUIFAX INC EFX · Entity 3235 | Tax withholdingCommon Stock | 3,665 | $158.25 | $579,986.25 |
DisclosureSEC source: 0001225208-20-004649 · doc4.xml · nonDerivative · entry 1 Farshchi Jamil · CIK 0001732980 · CISO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,203 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:56 UTC | EQUIFAX INC EFX · Entity 3235 | GrantStock Option/Right to Buy · Derivative | 4,925 | $0.00 Strike: $175.48 | $0.00 |
DisclosureSEC source: 0001225208-20-003459 · doc4.xml · derivative · entry 3 Farshchi Jamil · CIK 0001732980 · CISO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,925 Underlying: Common Stock · 4,925 shares Expires 2026-02-21 F3 · derivative.exercise_date: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning 2/21/2021. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:56 UTC | EQUIFAX INC EFX · Entity 3235 | GrantStock Option/Right to Buy · Derivative | 6,213 | $0.00 Strike: $191.44 | $0.00 |
DisclosureSEC source: 0001225208-20-003459 · doc4.xml · derivative · entry 2 Farshchi Jamil · CIK 0001732980 · CISO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,213 Underlying: Common Stock · 6,213 shares Expires 2026-02-21 F3 · derivative.exercise_date: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests in three equal annual increments beginning 2/21/2021. Read SEC document |
| February 21, 2020 Filed Feb 25, 2020 21:56 UTC | EQUIFAX INC EFX · Entity 3235 | GrantCommon Stock | 1,410 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-003459 · doc4.xml · nonDerivative · entry 1 Farshchi Jamil · CIK 0001732980 · CISO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,868 F1 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The award of restricted stock units vests 100% on 2/21/2023. F2 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| March 05, 2019 Filed Mar 7, 2019 21:33 UTC | EQUIFAX INC EFX · Entity 3235 | Tax withholdingCommon Stock | 4,238 | $109.91 | $465,798.58 |
DisclosureSEC source: 0001225208-19-004893 · doc4.xml · nonDerivative · entry 1 Farshchi Jamil · CIK 0001732980 · CISO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,310 F1 · balance_after: Includes accrued dividend equivalent units for dividends reinvested in corresponding restricted stock units through the Company's last dividend payment date. Read SEC document |
| February 22, 2019 Filed Feb 27, 2019 01:30 UTC | EQUIFAX INC EFX · Entity 3235 | GrantStock Option/Right to Buy · Derivative | 9,171 | $0.00 Strike: $127.37 | $0.00 |
DisclosureSEC source: 0001225208-19-003791 · doc4.xml · derivative · entry 4 Farshchi Jamil · CIK 0001732980 · CISO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,171 Underlying: Common Stock · 9,171 shares Expires 2025-02-22 F3 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests 100% on 2/22/2022. Read SEC document |
| February 22, 2019 Filed Feb 27, 2019 01:30 UTC | EQUIFAX INC EFX · Entity 3235 | GrantStock Option/Right to Buy · Derivative | 11,089 | $0.00 Strike: $138.45 | $0.00 |
DisclosureSEC source: 0001225208-19-003791 · doc4.xml · derivative · entry 3 Farshchi Jamil · CIK 0001732980 · CISO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,089 Underlying: Common Stock · 11,089 shares Expires 2025-02-22 F3 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests 100% on 2/22/2022. Read SEC document |
| February 22, 2019 Filed Feb 27, 2019 01:30 UTC | EQUIFAX INC EFX · Entity 3235 | GrantStock Option/Right to Buy · Derivative | 13,367 | $0.00 Strike: $149.53 | $0.00 |
DisclosureSEC source: 0001225208-19-003791 · doc4.xml · derivative · entry 2 Farshchi Jamil · CIK 0001732980 · CISO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,367 Underlying: Common Stock · 13,367 shares Expires 2025-02-22 F3 · security: Annual equity grant pursuant to the Company's long-term incentive plan. The option vests 100% on 2/22/2022. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.